FundedIQ
Biotechnology

Ubives: Funding, Investors & Team (Sep 2026)

Ubives is an innovative user management tool that transforms the way online identification and data management are handled. It eliminates the need for passwords, making logins easier and reducing security risks. By seamlessly integrating with various services and systems, it offers businesses substantial cost savings compared to traditional identification methods. Its goal is to enhance online security and convenience by providing cutting-edge solutions for digital identity management.

www.ubives.com LinkedIn Budapest, Hungary 1-10 employees
Biometrics Cloud Management Cloud Security Cyber Security Identity Management Private Cloud SaaS B2B
Total raised
$10k
Rounds
1
Latest
Pre-Seed
Jul 2024

Ubives has raised $10k across 1 funding round on record, the most recent a Pre-Seed of $10k announced in Jul 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Ubives Company Profile and Key Stats

Total funding raised
$10k
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$10k in Jul 2024
Employees
1-10
reported band
Headquarters
Budapest, Hungary

Latest funding round on record: Jul 2024.

Ubives Funding Rounds

Date
Round
Amount
Pre-Seed
$10k

Ubives Founders and Leadership Team

Name
Role
Contact
Marcel Nyiro
Founder
Locked

Contact details for the Ubives team: 1 of 1 has an email address on file.

Start 14-day free trial →

Ubives Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
42
$7.2M
5,801
$600K

Ubives' latest round of $10k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Ubives in Biotechnology and Budapest

Companies Similar to Ubives

VRG Therapeutics is a biotech firm specializing in miniprotein-based drugs and cellular and gene therapy…

Series A $5.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…

Series B $7.3M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Ubives Funding FAQs

What does Ubives do?

Ubives is an innovative user management tool that transforms the way online identification and data management are handled. It eliminates the need for passwords, making logins easier and reducing security risks. By seamlessly integrating with various services and systems, it offers businesses substantial cost savings compared to traditional identification methods. Its goal is to enhance online security and convenience by providing cutting-edge solutions for digital identity management.

How much funding has Ubives raised?

Ubives has raised $10k across 1 round on record. The most recent is a Pre-Seed of $10k announced in Jul 2024.

When did Ubives last raise funding?

Ubives' most recent funding round on record is a Pre-Seed of $10k, announced in Jul 2024.

Who founded Ubives?

FundedIQ lists Marcel Nyiro (Founder) at Ubives.

Where is Ubives headquartered?

Ubives is based in Budapest, Hungary.

How many employees does Ubives have?

Ubives is in the 1-10 employee band.

How does Ubives' funding compare to other Biotechnology startups?

Ubives' latest round of $10k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Ubives Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ubives is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.